2014-02-17 04:11:01 - Physician Views: Key Developments in the European Diabetes Market - Will Endocrinologists Embrace Tresiba and Forxiga? - Both Rejected by the FDA - a new market research report on companiesandmarkets.com
This week´s Physician Views poll will specifically ask endocrinologists based in the 5EU countries:
- To what percentage of eligible patients they anticipate prescribing Tresiba to in a year´s time?
- Whether the FDA´s decision not to approve Tresiba (pending data from a cardiovascular outcomes study) will have any impact on your own prescribing of the product?
- How endocrinologists describe their initial usage of Forxiga
- To what percentage of total diabetes patients they expect to be prescribing SGLT-2 inhibitors to in two years time?
- Based on usage to date where they believe the most likely to use SGLT-2 inhibitors within the treatment paradigm?
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and
Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.